September 16, 2016

LabCorp Subsidiary Sequenom Inc. Announces Tender Offers and Consent Solicitations for 5% Convertible Senior Notes Due 2017 and 5% Convertible Senior Exchange Notes Due 2018

BURLINGTON, N.C. & SAN DIEGO --(BUSINESS WIRE)--Sep. 16, 2016-- Sequenom, Inc. , a wholly-owned subsidiary of Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH), announced the commencement of cash tender offers (the “Tender Offers”) for any and all of the outstanding 5%
Read more »
August 23, 2016

LabCorp’s Acquisition of Sequenom Clears Antitrust Review

BURLINGTON, N.C. --(BUSINESS WIRE)--Aug. 23, 2016-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE:LH) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, applicable to the acquisition of Sequenom, Inc.
Read more »
August 2, 2016

LabCorp Announces the Availability of the CDC Zika MAC-ELISA Test

The CDC Zika MAC-ELISA Test Has Received FDA Emergency Use Authorization and Complements the RealStar ® Zika Virus RT-PCR Kit U.S. BURLINGTON, N.C. --(BUSINESS WIRE)--Aug. 2, 2016-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE:LH) today announced the nationwide availability of
Read more »
July 27, 2016

LabCorp Announces Agreement to Acquire Sequenom

Acquisition Creates Market Leader in NIPT, Women’s Health and Reproductive Genetics LabCorp CEO: ‘This is exactly the kind of strategic acquisition that LabCorp seeks’ BURLINGTON, N.C. & SAN DIEGO --(BUSINESS WIRE)--Jul. 27, 2016-- Laboratory Corporation of America®   Holdings (LabCorp®)
Read more »